Fellow research   [Current.....]

Archive

October 19, 2018

The Addition of Olanzapine to Ondansetron and Dexamethasone for Prevention of Chemotherapy-Induced Nausea and Vomiting: A Randomized, Double-blind, Placebo-controlled, Crossover Study.

Veerisa Vimolchalao, Siwat Sakdejayont, Ploytuangporn Wongchanapai, Shama Sukprakun, Pattama Angsapatt, Wilai Thawinwisan, Piyachut Chenaksara, Suleeporn Uttamapinan, Nattaya Sintawichai, Nattaya Poowarawan, Piyada sitthidechpaiboon, Napa Parinyanitikun, Chanida Vinayanuwatikun, Virote Sriuranpong, Suebpong Tanasanvimon

October 19, 2018

A Randomized, Double Blind, Placebo-Controlled Study Evaluating Efficacy of Combination Olanzapine, Ondansetron and Dexamethasone for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Doxorubicin plus Cyclophosphamide

Wipada Nipondhkit, Kunlatida Maneenil, Sunatee Sa-nguansai, Songwit Payapwattanawong, Sudsawat Laohavinij, Jedzada Maneechavakajorn, Piyawan Tienchaiananda

October 19, 2018

Association between dietary patterns with disease recurrence in Thai colorectal cancer patients

Vorraaud Kunnavuttivanich, Pornpoj Pramyothin, Suthinee Ithimakin

October 19, 2018

Hypothyroidism in cancer patients inhibitors : Risk factors and Outcomes

Sitsada Hansuranant, Hataikarn Nimitphong, Oraluck Pattanaprateep, Dittapol muntham, Runya Phraewphiphat, Thanyanan Reungwetwattana

October 19, 2018

Tolerability and Treatment Outcomes of Recurrent/Metastasis Nasopharyngeal Carcinoma: A Retrospective Analysis

Chatsuda Sookthon, Poompis Pattaranutaporn, Pawin Numthavaj, Nuttapong Ngamphaiboon

October 19, 2018

Survival benefit of adjuvant chemotherapy VS active surveillance in locally advanced nasopharyngeal carcinoma in Siriraj hospital

Chatchanok Paoin, Nuttapong Ngamphaiboon, Arunee Dechaphunkul, Pongwut Danchaivijitr

October 19, 2018

The Outcomes of Multi-modality Treatment for Patients with Squamous Cell Carcinoma of Head and Neck (SCCHNC) in Vajira Hospital

Sarat Chalongpoksinchai, MD

October 19, 2018

Retrospective study of gemcitabine plus low dose cisplatin as first line treatment in metastatic or unresectable biliary tract cancer in Northern region of Thailand, 5 years experience

Kijjakom Thanasombunsukh, Busyamas Chewaskulyong

October 19, 2018

No overall survival difference with gemcitabine-based compared with fluorouracil-based chemotherapy in advanced cholangiocarcinoma

Naphapatt Mungwatthana, Aumkhae Sookprasert, Kosin Wirasorn, Jarin Chindaprasirt

October 19, 2018

Evaluation of treatment efficacy in advanced hepatocellular carcinoma patients receiving sorafenib or cytotoxic chemotherapy in Phramongkutklao hospital; a retrospective study

Chonnipa Ruansan, Siriwimon Saichaemchan, Kasan Seetalarom, Naiyarat Prasoongsook. Khunthong Pechatanan

October 19, 2018

p16 and BRAF Immunohistochemistry as a screening assay in MLH-1 deficient colorectal cancer

Maturos Soukavanitch, Artit Jinawath, Asst. Prof. Atchara Tunteeratum, Assist. Prof. Pattana Sornmayura, Bhutorn Sukwanitch, Assoc. Prof. Ravat Panvichien

October 19, 2018

Prognostic value of Tumor-infiltrating lymphocytes (TILs) and clinical values for Prediction of Breast Cancer Recurrence in HER2 Positive Early Breast Cancer after Surgery in King Chulalongkorn Memorial Hospital

Surampa Prapatsornvichit, Taywin Atikankul and Napa Parinyanitikul

October 19, 2018

Diagnostic significance of serum urokinase plasminogen activator receptor in recurrent breast cancer in King Chulalongkorn Memorial Hospital

Prapassorn Thirasastr, Siriporn Khunsri, Napa Parinyanitikul

October 19, 2018

Clinical characteristic and clinical outcomes of renal cell carcinoma in Ramathibodi hospital

Piyaporn Srikaew, Suchin Worawichawong, Phichai Chansriwong

October 19, 2018

Level of cyclin D1 expression in non-small cell lung carcinoma with and without Kirsten rat sarcoma (KRAS) mutation

Passakorn Wanchaijiraboon, Sutima Luangdilok, Poonchavist Chantranuwat, Virote Sriuranpong

October 19, 2018

Plasma T-cell-derived circulating DNA level in advanced stage non-small cell lung cancer is not correlated with tumor-infiltrated lymphocyte but has a potential of prognostic value

Weerasubpong B, Vinayanuwattikun C, Chantranuwat P, Sriuranpong V

October 19, 2018

PD-L1 Expression as a Predictive Biomarker in Advanced Non- Small Cell Lung Cancer Patients with or without EGFR Mutation

Teerada Siripoon, Pimpin Incharoen, Narumol Trachu, Dittapol Munthum, Kaettipong Kamprerasart, Thanyanan Reungwetwattana

October 19, 2018

Treatment Impact on Survival of Early Stage NSCLC: Phramongkutklao Hospital Experience

P. Limpawittayakul MD, N. Prasongsook MD, K. Seetalarom MD, K. Peechatanan MD and S. Saichaemchan MD

December 15, 2017

Clinical Characteristics and Outcomes of Extremity Soft Tissue Sarcoma in Siriraj Hospital

Nichanan Tanapathomsinchai, Suvimol Niyomnaitham, Tuangtham Anekpurithanang and Jomjit Chantharasamee

December 15, 2017

Tolerability and Efficacy of Concurrent Chemoradiotherapy Comparing Carboplatin/Paclitaxel vs Platinum/5-FU Regimen for Locally Advanced Esophageal and Esophagogastric Junction Cancers

Amorn Tamtai, Chuleeporn Jiarpinitnun, Pitichote Hiranyatheb, Nattawut Unwanatham, Eakapop Sirachainun, Chairat Supsamutchai, Poompis Pattaranutaporn and Nuttapong Ngamphaiboon

December 15, 2017

Prognostic factors of Survival Outcomes in Thai Colorectal Cancer Patients with Liver Metastasis

Pimtip Sanvarinda, Somkit Mingphruedhi, Manmana Jirajarus, Prapai Chengtawee and Ekaphop Sirachainan

December 15, 2017

Isocitrate Dehydrogenase1 and 2 Mutations in Thai Patients with Cholangiocarcinoma

Bhuritatt Sutthiprapa, Anapat Sanpavat, Virote Sriuranpong, Chanida Vinayanuwattikun, Napa Parinyanitikul, Nattaya Poovorawan, Piyada Sithidetphaiboon, Nakarin Kitkumthorn, Siriporn Khunsri, Prapatsorn Rattanachayoto, Chatcha Phromma and Suebpong Thanasarnvimon

December 15, 2017

Role of Metformin, Aspirin and Statin in Cancer Prevention: A Population- Based Study

Phetchoo P, Oranratnachai S, Rattanasiri S, Thakkinstian A, Thongmung N, Khaing W, Aiempradir S, Vathesatogkit P, Sritara P and Reungwetwattana T

December 15, 2017

Predisposing factors associated with chemotherapy toxicity in elderly cancer patients: A prospective study

Ekkamol Phaibulvatanapong, Varalak Srinonprasert and Suthinee Ithimakin

December 15, 2017

Early Palliative Care Reduced the Aggressiveness of Cancer Care near End of Life in Metastatic Non Small Cell Lung Cancer Patients

Wandee Chanprasertpinyo, Siriporn Semsarn, Nattapong Ngamphaiboon, Viratch Tangsujaritvijit, Thanyanan Reungwetwattana, Veerachai Sachdev and Phichai Chansriwong

December 15, 2017

Expected Years of Life Loss and Survival Outcome in Non-small Cell Lung Cancer Patients in Rajavithi Hospital

Sunatee Sa-nguansai, Piyawan Tienchaiananda, Songwit Payapwattanawong and Sudsawat Laohavinij

December 15, 2017

Nutritional and systemic inflammatory response parameter and survival outcomes in the inoperable non-small cell lung cancer patients treated with palliative chemotherapy in Rajavithi hospital

G Pisuth , M Jedzada

December 15, 2017

Outcome of treatment with 2nd or 3rd line TKI in Recurrent/Advance NSCLC Patients In Maharaj Nakhon Chiangmai Hospital

Neelanut Charoenchasri, ApichatTantraworasin and Thatthan Suksombooncharoen

December 15, 2017

The efficacy of Bevacizumab adding in standard first line chemotherapy and maintenance treatment in advanced stage NSCLC: a systematic review and network meta-analysis

Vichapat V, Reungwetwattana T and Thakkinstian A

December 15, 2017

Obesity and outcome of operable breast cancer in Thai patient: A single center study

Tanapat Engkakul and Charuwan Akewanlop

December 15, 2017

Correlation between of serum 25-hydroxyvitamin D (25(OH)D) level and bone mineral density (BMD) change in postmenopausal women with early breast cancer receiving aromatase inhibitors

Nattaya Sintawichai, Lalita Wattanachanya, Virote Sriuranpong, Chanida Vinayanuwattikun, Napa Parinyanitikul, Nattaya Poovorawan, Piyada Sithidetphaiboon and Suebpong Tanasanvimon

December 15, 2017

A double-blind, placebo-controlled randomized phase II study: evaluating the effect of curcumin for treatment of cancer anorexia–cachexia syndrome in solid cancer patients.

Aornchuma Chaiworramukkul, Kasan Seetalarom, Siriwimon Saichaemchan, Khunthong Pechatanan, Naiyarat Prasoongsook

December 15, 2017

A Clinicopathological Prediction Model for Recurrence in Patients with Early-staged Hormonal Receptor Positive, Her-2 Negative Breast Cancer at King Chulalongkorn Memorial Hospital

Suleepon Uttamapinan, Kroonpong Iampenkhae, Thanapoom Rattananupong, Nattaya Poovorawan, Virote Sriuranpong, Aisawan Petchlorlian and Napa Parinyanitikul

December 15, 2017

Change of Programmed Cell Death 1 Ligand Expression in Non Small Cell Lung Carcinoma Harboring Somatic Epidermal Growth Factor Receptor (EGFR) Mutations Correlated with EGFR Tyrosine Kinase Inhibitors Exposure

Siwat Sakdejayont, Poonchavist Chantranuwat and Virote Sriuranpong

September 9, 2016

A study of proteomics pattern of tissue subtypes of lung adenocarcinoma in the King Chulalongkorn Memorial Hospital

Benyapatch Eiamthanasinchai, M.D., Thammakorn Saethang, M.D., Trairak Pisitkun, M.D., Poonchavist Chantranuwatana, M.D. and Virote Sriuranpong, M.D.

September 9, 2016

Serum CYFRA 21-1 and CEA level as predicting markers for non-small cell lung cancer stages III and IV

Punlert Tanyakul, M.D., Apichat Tantraworasin, M.D. and Busyamas Chewaskulyong, M.D.

September 9, 2016

Outcome and Characteristics of Lung Cancer Patients That Non-Received Treatment in Maharaj Nakorn Chiangmai Hospital

Anantaporn Pooprasert, M.D. and Chaiyut Charoentum, M.D.

September 9, 2016

Programmed death ligand-1 (PD-L1) expression in Resectable Cholangiocarcinoma Patients in Srinakarind Hospital

Piangpen Jongpairat, M.D.

September 9, 2016

Evaluation of clinical predictive model for chemotherapy induced febrile neutropenia in breast cancer at Rajavithi Hospital

Chaichana Chantharakhit, M.D., Jedzada Maneechavakajorn, M.D.

September 9, 2016

Survival outcome of advanced non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitors in Rajavithi Hospital

Pajeepatoo Wannarat, M.D., Songwit Payapwattanawong, M.D., Sudsawat Laohavinij, Ph.D. M.D. and Piyawan Tainchaianan, M.D.

September 9, 2016

Explanation Models Using Pathological Data for Clinical Treatment Outcome of Early-Stage Breast Cancer Patients With Hormonal Receptor (HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative

Sukhanit Promrub, M.D., Siriwimon Saichaemchan, M.D., Khunthong Pechatanan, M.D., Kasan Seetalarom, M.D. and Naiyarat Prasoongsook, M.D.

September 9, 2016

Incidence Throbocytopenia in Colon Stage III Who Received Oxaliplatin Base Regimen

Praewphan Ruangekawit, M.D., Nuttapong Ngamphaiboon, M.D. and Ekaphop Sirachainan, M.D.

September 9, 2016

Comparison of C-telopeptide of Original Zoledronate and Generic Zoledronate in Cancer Patients with Bone Metastasis

Nathamon Panomuppakarn, M.D. and Thitiya Dejthevaporn, M.D.

September 9, 2016

Prevalence, Pattern and Impact of PD-L1 Expression and HPV-status in Head and Neck Squamous Cell Carcinoma

Theeranut Chureemas, M.D., Noppadol Larbcharoensub, M.D., Jitlada Juengsamarn, M.D., Thanarat Layangkool, M.D., Chutima Jiarpinitnun, M.D., Phichai Chansriwong, M.D., Narumol Trachu, Poompis Pattaranutaporn, M.D. and Nattapong Ngamphaiboon, M.D.

September 9, 2016

The Impact of Age In Treatment Outcome of Squamous Cell Carcinoma In Head and Neck Cacncer Patient

Jitlada Juengsamarn, M.D., Nuttapong Ngamphaiboon, M.D., Chuleeporn Jiarpinitnun, M.D., Poompis Pattaranutaporn, M.D. and Phichai Chansriwong, M.D.

September 9, 2016

Role of BIM Deletion Polymorphism and BIM Expression As The Predictive Biomarkers To Maximize The Benefit of EGFR TKI Treatment In EGFR Positive NSCLC

Chanchai Charonpongsuntorn, M.D., Pimpin Incharoen, M.D., Narumol Trachu, Kaettipong Kampreasart, M.D., Dittapol Muntham, Sakditad Saowapa, M.D., Ekaphop Sirichainan, M.D. and Thanyanan Reungwetwattana, M.D.

September 9, 2016

Overall Survival In Patients With Non-metastatic Muscle-invasive Bladder Cancer (Stage II-IV) Receiving Neoadjuvant or Adjuvant Chemotherapy In Siriraj Hospital

Chayanee Samdaengpan, M.D., ChalairatSuk-ouichai, M.D. and Sirisopa Techawattanawanna, M.D.

September 9, 2016

Male breast cancer: Treatment outcome at Siriraj hospital: 10-year experience

Patraporn Maneenawachai, M.D. and Vichien Srimuninnimit, M.D.

September 9, 2016

Efficacy of Ginger for Chemotherapy-induced Nausea and Vomiting Prophylaxis In Breast Cancer Patients Receiving Adriamycin – Cyclophosphamide Regimen: A Randomized Double-blind Placebo-control Crossover Study

Lucksamon Thamlikitkul, M.D., Vichien Srimuninnimit, M.D., Charuwan Akewanlop, M.D., Suthinee Ithimakin, M.D., Sirisopa Techawathanawanna, M.D., Krittiya Korphaisarn, M.D., Jomjit Chantharasamee, M.D., Pongwut Danchaivijitr, M.D., Nopadol Soparattanapaisarn, M.D.

September 9, 2016

Cost Effective Analysis of EGFR Mutation Testing Before Initiation of Second Line Therapy In Advanced Adenocarcinoma of Lung

Tanawade Sirithanadepan, M.D.

September 9, 2016

The Accuracy of Carboplatin Area Under the Plasma Concentration Time Curve (AUC) Estimated by Calvert Formula Using Cockcroft-Gault formula and Thai eGFR in Thai Cancer Patients

Kokiet Kangwantas, M.D., Panneeb Chinjarernpan, Viroteb Sriuranpong, Napab Parinyanitikul, Piyadab Sitthideatphaiboon, Nattayab Poovorawan, and Suebpong Tanasanvimon, M.D.

September 9, 2016

Incidence of Infusion Hypersensitivity Reaction After Withholding Dexamethasone Premedication in Early Breast Cancer Patients Not Experiencing Two Previous Cycles of Infusion Hypersensitivity Reaction for Weekly Paclitaxel Chemotherapy

Walailuk Tanpipattanakul, M.D., Nattaya Poovorawan, M.D., Thanapoom Rattananupong, M.D., Poranee Laoitthi, M.D., Piyada Sithidetphaiboon, M.D., Suebpong Thanasanvimon, M.D., Virote Sriuranpong, M.D. and Napa Parinyanitikul, M.D.

September 9, 2016

การตรวจสอบและประเมินเวชระเบียนในผู้ป่วยกลุ่มโรคมะเร็งเต้านมของโรงพยาบาลพระมงกุฎเกล้า

กิตติยา ศรีกิตวิยาสิยางกูร พ.บ.

September 9, 2016

Clinical Prognostic Factors and Genomic Alterations of Cholangiocarcinoma in Thai Population

Weeranuch Rattanadech, M.D., Narumol Trachu, Noppadol Larbcharoensub, M.D., N. Monnamo, Kaettipong Kamprerasart, M.D., Dittapol Muntham, Ekaphop Sirachainan, M.D., Thanyanan Reungwetwattana, M.D.

September 9, 2016

The Study of TTF-1 Expression and Mutation Specific-antibody for Detection of EGFR Gene Mutation in Non-small Cell Lung Cancer

Chumut Phanthunane, M.D., Chaiyut Charoentum, M.D., Nirush Lertprasertsuke, M.D. and Busayamas Chewaskulyong, M.D.

September 9, 2016

Incremental Cost-Effectiveness Analysis of Hepatic Metastasectomy in Patients with Advanced Colon Cancer and Liver Metastasis

Supreeda Chainitikun, M.D., Virote Sriuranpong, M.D. and Piya Hanvoravongchai, M.D.

September 9, 2016

Correlation Between LINE-1 Methylation and MGMT Promoter Methylation in Glioblastomas

Jarin Chindapasirt, M.D., Piyamai Chankate, M.D., Mathawee Aumchaaumchaya, M.D., Chinachote Teerapakpinyo, M.D., Iyavut Thaipisuttikul, M.D., Shanop Shuangshoti, M.D. and Virote Sriuranpong, M.D.

September 9, 2016

Effect of Complimentary and Alternative Medicine on Chemotherapy Dose reduction and delay in Thai Patients with breast, lung and colon cancers at King Chulalongkorn Memorial hospital

Chawanya Rabiltossaporn, M.D. and Suebpong Tanasanvimon, M.D.

September 9, 2016

Dietary counseling outcomes in locally advanced unresectable or metastatic cancer patients undergoing chemotherapy

Napawan Sukaraphat, M.D., Busyamas Chewaskulyong, M.D. and Supawan Buranapin, M.D.

September 9, 2016

การศึกษาอุบัติการณ์ภาวะตับวายเฉียบพลันตามหลังการให้ยาเคมีบำบัดทางหลอดเลือดแดงในผู้ป่วยมะเร็งตับชนิดเฮพาโตเซลลูลาร์คาร์ซิโนมา

หะริน ศรีจุดานุ พ.บ. และ กสานติ์ สีตลารมณ์ พ.บ.

September 9, 2016

A Pilot Study of Clinical Prognostic Factors Including ROS1 Translocation and ALK Expression of Cholangiocarcinoma Patients in Ramathibodi Hospital

Supoj Detarkom, M.D., Narumol Trachu, M.D., Noppadol Larbcharoensub, M.D., N. Monnamo, Kaettipong Kamprerasart, M.D., Dittapol Muntham, A. Jinawat, Ekaphop Sirachainan, M.D. and Thanyanan Reungwetwattana, M.D.

September 9, 2016

Pahological Complete Response After Neoadjuvant Chemotherapy and Outcones in Non-metastatic Breast Cancer at Siriraj Hospital

Sutima Luangdilok, Ph.D. M.D., Norasate Samarnthai, M.D., Krittiya Korphaisarn, M.D.

September 9, 2016

A Prospective Study of Prophylactic Gastrostomy in Head and Neck Cancer Patients Undergoing Chemoradiotherapy in Real-world Practice

Sorrapong Manyanont, M.D., Pornpoj Pramyothin, M.D. and Suthinee Ithimakin, M.D.

September 9, 2016

Natural History of Primary High-risk Gastrointestinal Stromal Tumor After Surgery in THAI Patients

Sarunporn Techasurungkul, M.D., Ananya Manuyakorn, M.D., Vichien Srimuninnimit, M.D.

September 9, 2016

Survival of Metastatic Breast Cancer (MBC) Patients at Rajavithi Hospital

Vinai Paul, M.D., Kunlatida Maneenil M.D. and Sudsawat Laohavinij, Ph.D. M.D.

September 9, 2016

MicroRNA-200C Expression in Cholangio-carcinoma Patients at King Chulalongkorn Memorial Hospital

Warit Loywirat, M.D., Virote Sriuranpong, M.D. and Suebpong Tanasanvimon, M.D.

September 9, 2016

Survival Outcomes of Metastatic/Unresectable Hepatocellular Carcinoma in Patients Treated With Sorafenib

Jomjit Chantharasamee, M.D., Sirisopa Techawattanawanna, M.D., Watcharasak Chotiyaputta, M.D. and Akkarin Nimmannit, M.D.

September 9, 2016

Association of Plasma CXCL12 Level and Bone Metastasis in Advance Stage Non-small Cell Lung Cancer Patients in King Chulalongkorn Memorial Hospital

Sunee Neesanun, M.D. and Virote Sriuranpong, M.D.

September 9, 2016

A Difference in Grade3 and 4 Hypersensitivity Reactions Between Original and Generic Drugs of Taxane Group

Tanchanok Ratanajarusiri, M.D., Virote Sriuranpong, M.D. and Suebpong Tanasanvimon, M.D.

September 9, 2016

Serum Amphiregulin in Colorectal Carcinoma and The Correlation with Liver Metastasis in King Chulalingkorn Memorial Hospital

Chawalit Chayangsu, M.D. and Virote Sriuranpong, M.D.

September 9, 2016

Survival and Prognostic of Stage IV Bladder Cancer in Rajavithi Hospital

Sitthi Sukauichai, M.D., Sudsawat Laohavinij, Ph.D. M.D., Piyawan Tienchaiananda, M.D.

September 9, 2016

Correlation of Mitotic Index and Ki-67 And Their Impacts on Survival of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at Ramathibodi Hospital

Vigrom Jennetisin, M.D., Thitiya Dejthevaporn, M.D., Pattana Sornmayura, M.D., Dittapol Muntham and Sasivimol Rattanasiri

September 9, 2016

Prognostic Factors For survival in Soft Tissue Sarcoma: Rajavithi Hospital Experience

Phungern Khongthong, M.D., Jedzada Maneechavakajorn, M.D. and Kunlatida Maneenil, M.D.

September 9, 2016

Prevalence of Retinoblastoma Protein in Negative Human Papilloma Virus in Non-nasopharyngeal Head and Neck Squamous Cell Carcinoma in Patients at The King Chulalongkorn Memorial Hospital

Panunat Muangnoi, M.D., Somboon Keelawat, M.D., Chanida Vinayanuwattikun and Virote Sriuranpong, M.D.

September 9, 2016

Adherence to Adjuvant Chemotherapy Among Early Stage Breast Cancer Patients in Single Referral Medical Center

Pensupa Raweelert, M.D., Sodsai Ketnai, M.D., Chalermsri Naewjumpa, M.D., Pakawan Promruang, M.D. and Nopadol Soparattanapaisarn, M.D.

September 9, 2016

Clinical Outcome of HER2-positive, Node-negative Breast Cancer Patients in Siriraj Hospital

Pornsira Hongsakul, M.D., Suthinee Ithimakin, M.D., Parvinee Suwanagool, M.D. and Vichien Srimuninnimit, M.D.

September 9, 2016

Incidence And Risk Factor Of Venous Thromboembolism In Northern THAI Cancer Receiving Chemotherapy Patients

Piyanoot Jitthiang, M.D., Sumitra Thongprasert, M.D., Busayamas Cheewasakulyong, M.D., Chaiyut Charoenthum and Witthawat Ariyawatayakorn, M.D.

September 9, 2016

Androgen Receptor Expression in Triple Negative Breast Cancer in Ramathibodi Hospital

Thipawan Bowornkitiwong, M.D., Touch Ativitatvas, M.D., Niramol Chanplakorn, M.D., Sansanee Wongwaisayawan, M.D., Thitiya Sirisinha, M.D., Ekaphop Sirachainan, M.D., Ravat Panvichian, M.D. and Vorachai Ratanatharathorn, M.D.

September 9, 2016

Preoperative Versus Postoperative Chemotherapy in Rectal Cancer: Ramathibodi Experience

Narong Chaivuthinun, M.D., Touch Ativitavas, M.D., Umaporn Udomsubpayakul, M.D., Thitiya Sirisinha, M.D., Ekaphop Sirachainan, M.D., Ravat Panvichian, M.D. and Vorachai Ratanatharathorn, M.D.

September 9, 2016

การศึกษาผลการรักษาและค่ารักษาพยาบาลในผู้ป่วยโรคมะเร็งลาไส้ใหญ่ระยะแพร่กระจายที่ได้รับยา Bevacizumab ร่วมกับยาเคมีบาบัด

จีรวัฒน์ พรายทองแย้ม พ.บ., สาวิตรี เมาฬีกุลไพโรจน์ พ.บ., กสานติ์ สีตลารมณ์ พ.บ., สุรีรัตน์ จารุหทัย พ.บ. และ ดลพรรษ พันธุ์พาณิชย์ พ.บ.

September 9, 2016

Clinical Outcome Of Stage II-IVB Nasopharyngeal Carcinoma Patients Treated With Concurrent Chemoradiation At Seriraj Hospital

Khrongkamol Sihaban, M.D. and Charuwan Akewanlop, M.D.

September 9, 2016

Four Dihydropyrimidine Dehydrogenase Genotypes (1627A>G, 967G>A, 1774C>T and IVS14+G>A) As A Predictive Factors For Toxicity In THAI Patients Treated With Single Agent 5-FU or Capecitabine In Ramathibodi Hospital

Somjai Chanchairungcharoen, M.D., Narumol Trachu, M.D., Touch Ativitatvas, M.D., Thitiya Sirisinha, M.D., Ravat Panvichian, M.D., Vorachai Ratanatharathorn, M.D. and Ekaphop Sirachainan, M.D.

September 9, 2016

The 1-Year Outcomes Following Liver Resection For Liver Metastasis Colorectal Cancer In King Chulalongkorn Memorial Hospital

Thitima Klomkleao, M.D. and Virote Sriuranpong, M.D.

September 9, 2016

Prevalance of KRAS Gene Mutation in Ampullary Cancer in THAI Patients

Piyada Sitthideatphaiboon, M.D., Naruemon Klaikaew, M.D., Ubon Pumsuk, M.D., Napa Parinyanitikul, M.D., Chanida Vinayanuwattikun, M.D., Suebpong Tanasanvimon, M.D. and Virote Sriuranpong, M.D.

September 9, 2016

Detection Rate of SFTPB and KRT14 Expression by Immunohistochemistry Method in Squamous Cell Carcinoma of Lung and Head-Neck Cancer Tissue

Nattaya Poovorawan, M.D., Poonchavist Chantranuwat, M.D., Somboon Keelawat, M.D., Preecha Ruangvejvorachai, M.D., Jutamas Wongphoom, M.D., Suebpong Tanasanvimon, M.D., Chanida Vinayanuwattikun, M.D. and ViroteSriuranpong, M.D.

September 9, 2016

A Randomized, Open-Label, Single Center Trial Comparing Toxicity of Cisplatin Plus Gemcitabine in Treatment of Unresectable Cholangiocarcinoma: Conventional Regimen Versus The UK ABC-02 Trial - Preliminary Report

Woraporn Sinsuwan, M.D., Busyamas Chewasakulyong, M.D., Chaiyut Charoentum, M.D., Witthawat Ariyawutyakorn, M.D., Piyanoot Jitthiang, M.D., Chusak Sirivanichai, M.D., T.Srisuwan, M.D. and Sumitra Thongprasert, M.D.

September 9, 2016

The Thymidylate Synthase Promoter Enhancer Region (TSER) Polymorphism As A Predictive Factor of Adjuvant 5-FU Based Chemotherapy in THAI Colorectal Cancer Patients

Natchadol Kittiwararat, M.D., Ekaphop Sirachainan, M.D., Narumol Trachu, M.D., Touch Ativitavas, M.D., Thitiya Sirisinha, M.D., Rawat Panvichian, M.D., Pichai Chansriwong, M.D. and Vorachai Ratanatharathorn, M.D.

September 9, 2016

Oxaliplatin, Fluorouracil and Leucovorin As Adjuvant Treatment for Stage III Colon Cancer In Ramathibodi Hospital

Asasiri Kankaew , M.D., Touch Ativitatvas, M.D., Dittapol Muntham, M.D., Umaporn Udomsubpayakul, M.D., Thitiya Sirisinha, M.D., Ekaphop Sirachainan, M.D., Ravat Panvichian, M.D. and Vorachai Ratanatharathorn, M.D.

September 9, 2016

The Characteristic of Breast Cancers in Patients With and Without Diabetes Mullitus in Phramongkutklao Hospital

Warachai Krengwirat, M.D., Kasan Seetalarom, M.D., Naiyarat Prasongsook, M.D. and Siriwimon Saichaemchan, M.D.

September 9, 2016

Ki-67 As Predictive and Prognostic Factor for Node-negative, Hormone-positive Breast Cancer in Ramathibodi Hospital

Achaporn Petchdee, M.D., Touch Ativitatvas, M.D., Sansanee Wongwaisayawan, M.D., Umaporn Udomsubpayakul, M.D., Thitiya Sirisinha, M.D., Ekaphop Sirachainan, M.D., Ravat Panvichian, M.D. and Vorachai Ratanatharathorn M.D.

September 9, 2016

Prognostic Role of Thyroid Transcription Factor-1 (TTF-1) in Advanced Adenocarcinoma of Lung

Duangnapa Benjawongsathien, M.D. and Jezzada Maneechawakajorn, M.D.

September 9, 2016

Prevalence of PTEN Loss in Triple-negative Breast Cancer of THAI Females

Thiva Kiatpanabhikul, M.D., Napa Parinyanitikul, M.D., Voranuch Tanakit, M.D. and Virote Sriuranpong, M.D.

September 9, 2016

The Retrospective Comparison Study of Concurrent Chemoradiotherapy using Gemcitabine Versus Platinum in Locally Advanced Unresectable Squamous Cell Carcinoma of The Head and Neck

Nattha Pipopchaiyasit, M.D., Thitiya Dejthevaporn, M.D., Dittapol Muntham,M.D., Touch Ativitavas, M.D., Ravat Panvichian, M.D., Ekaphop Sirachainan, M.D. and Vorachai Ratanatharathorn, M.D.

September 9, 2016

The Predictive Value of Tumor Proliferative index (Ki67) for Adjuvant Chemotherapy in Node-negative, Hormone Receptor-positive Breast Cancer

Apisada Sutepvarnon, M.D., Vichien Srimuninnimit, M.D. and Malee Warnnissorn, M.D.

September 9, 2016

Prevalence of Defective DNA Mismatch Repair and BRAF Gene Mutation in Colorectal Cancer at Siriraj Hospital

Krittiya Korphaisarn, M.D.

September 9, 2016

Prevalence of Human Papillomavirus in Young Non-nasopharyngeal Head and Neck Squamous Cell Carcinoma in Patients at The King Chulalongkorn Memorial Hospital

Teerapat Ungtrakul, M.D., Jutamas Wongphoom, M.D., Somboon Kelawat, M.D., Chanida Winayanuwattikun, M.D. and Virote Sriuranpong, M.D.

September 9, 2016

Predictive Factors For Severe Neutropenia Following The First Cycle Chemotherapy In Breast Cancer Patients

Hataiwan Ratanabunjerdkul, M.D., Napa Parinyanitikul, M.D., Chanida Winayanuwattikun, M.D. and Virote Sriuranpong, M.D.

September 9, 2016

Clinical Characteristics and Disease Outcome of UICC Stages I-III Colorectal Cancer Patients at Siriraj Hospital

Sirisopa Techawathanawanna, M.D., Akarin Nimmannit, M.D. and Charuwan Akewanlop, M.D.

September 9, 2016

Retrospective analysis of elderly cancer patient, Ramathibodi hospital experience

Supachat Chompoonuch, M.D. and Thitiya Sirisinha, M.D.

September 9, 2016

Association of CYP2D6 polymorphisms and disease-free survival of Thai Breast cancer patients who received adjuvant tamoxifen

Khunthong Pechatanan, M.D., Ekaphop Sirachainan, M.D., Thitiya Sirisinha, M.D., Ravat Panvichian, M.D., Vorachai Ratanatharathorn, M.D., Wasun Chantratita, M.D. and Chonlaphat Sukasem, M.D.

September 9, 2016

The relationship between the excision repair cross-complementation group 1 (ERCC1) protein expression and outcome of oxaliplatin-based chemotherapy in metastatic colorectal cancer, Ramathibodi Experience

Kosin Wirasorn, M.D., Pattana Somyura, M.D. and Touch Ativitavas, M.D.

September 9, 2016

Level Of mRNA Of ACADVL Gene In Plasma In Asymptomatic Anthracycline Cardiotoxicity In Breast Cancer

Archara Supavavej, M.D., Virote Sriuranpong, M.D. and Sarinya Puwanant, M.D.

September 9, 2016

Prognostic factors for survival in Osteosarcoma : Rajavithi Hospital Experience

Kunlatida Maneenil, M.D. and Sudsawat Laohavinij, Ph.D M.D.

September 9, 2016

การศึกษาเรื่องมะเร็งเต้านมระยะศูนย์ หนึ่งและสองในผู้ป่วยอายุตั้งแต่ 70 ปีหรือมากกว่าเกี่ยวกับลักษณะของโรคและการรักษาที่ได้รับในโรงพยาบาลศิริราช

จอมธนา ศิริไพบูลย์ พ.บ. และ นพดล โสภารัตนาไพศาล พ.บ.

September 9, 2016

Extragonadal Germ Cell Tumors At Maharaj-Nakorn Chiangmai Hospital

Benjawan Kasemset, M.D. and Sumitra Thongprasert, M.D.

September 9, 2016

Prevalence of HER-2 positive in gastric cancer at Phramongkutklao Hospital

Kamkanok Nada, M.D., Naiyarat Prasongsook, M.D., Napat Angkathunyakul, M.D., Kasan Seetalarom, M.D.

September 9, 2016

การศึกษาอัตราการรอดชีพของผู้ป่วยมะเร็งระบบท่อทางเดินน้าดีในโรงพยาบาลราชวิถี

พรรษวรรณ ดำเล็ก พบ. และ เจษฏำ มณีชวขจร พบ.

September 9, 2016

C-reactive protein as a monitor of systemic therapy in advanced non-small cell lung cancer (CML Study)

Sarppasit Ariyapanya, M.D. and Vichien Srimuninnimit, M.D.

September 9, 2016

Prevalence Of Retinoblastoma Protein Loss By Immunohistochemistry In Tripple-negative Breast Cancer

Prakongboon Sungkasubun, M.D., Virote Sriuranpong, M.D. and Napa Parinyanitikul, M.D.

September 9, 2016

Incidence of HPV-associated p16INK4A positive in oropharyngeal cancer; Clinical presentations and treatment outcomes - Ramathibodi hospital experience

Chutima Petcharapirach, M.D., Touch Ativitavas, M.D., Noppadol Larbcharoensub, M.D., Wichit Cheewaruangroj, M.D., Umaporn Udomsubpayakul, M.D., Thitiya Sirisinha, M.D., Ekaphob Sirachainan, M.D., Ravat Panvichian, M.D., Vorachai Ratanatharathorn, M.D.

September 9, 2016

CA 19-9 in combination with abdominal CT scan for the diagnosis of mass-forming intrahepatic cholangiocarcinoma

Nilubol Raunroadroong, M.D., Hutcha Sriplung, M.D., Nirush Lertprasertsuke, M.D., Suwalee Pojchamarnwiputh, M.D., Witthanee Na Chiangmai, M.D., Worapon Sinsuwan, M.D. and Sumitra Thongprasert, M.D.

September 9, 2016

ERCC-1 Protein Expression and Its Correlation with Survival Rate in Patients with Advanced Non-small Cell Lung Cancer Receiving Cisplatin/Carboplatin-based Chemotherapy: a Retrospective study

Naritchaya Phattana, M.D.

September 9, 2016

การศึกษาการใช้ยาซิทูซิแมบ (Cetuximab) ในผู้ป่วยมะเร็งลาไส้ใหญ่ระยะแพร่กระจายที่มีผลการตรวจ K-ras mutation เป็น wild type ในโรงพยาบาลศิริราช

ศรัณย์ กิจศรัณย์ พบ. และ ณรงค์ กีรติวิทยานันท์ พบ.

September 9, 2016

Prevalance of K-RAS Genemutation in Pancreatic Cancer in Thai Patients

Wittawat Jitpewngarm, M.D. and Virote Sriuranpong, M.D.

September 9, 2016

Quality of Life of Old and New chemotherapy regimen in Advanced Non Small Cell Lung Cancer

จิรเจษฎ์ สุขสุเพิ่ม พบ. และ เจษฎา มณีชวขจร พบ.

September 9, 2016

RRM1 and ERCC1 protein expression in Cholangiocarcinoma: 5 Years Retrospective Study in Division of Medical Oncology, Maharaj Nakorn Chiang Mai Hospital

Thatthan Suksombooncharoen, M.D., Nirush Lertprasertsuke, M.D. and Sumitra Thongprasert, M.D.

September 9, 2016

Characteristics and Outcome of Early-onset Breast Cancer Patients at Siriraj Hospital

Siriwimon Saichamchan, M.D., Akarin Nimmannit, M.D. and Charuwan Akewanlop, M.D.

September 9, 2016

Role of HER2 overexpression as a prognostic factor in T1 breast cancer, Ramathibodi Experience

Luangyot Thongthieang, M.D., Touch Ativitavas, M.D., Sunsanee Wongwaisayawan, M.D., Nintita Sripaiboonkij, M.D., Thitiya Sirisinha, M.D., Ekaphop Sirachainan, M.D., Ravat Panvivchian, M.D. and Vorachai Ratanatharathorn, M.D.

September 9, 2016

KRAS mutation patterns and clinical outcomes of Thai patients with colorectal cancer receiving cetuximab

Autkittanon P, M.D. , Sirachainan E, M.D., Reukumneuychok B, M.D., Limsuwanachot N, M.D., Ativitavas T, M.D., Sirisinha T, M.D., Panvichian R, M.D. and Ratanatharathorn V, M.D.

September 9, 2016

The Benefit of Adjuvant Chemotherapy in Resected Early Stage NON-SMALL CELL LUNG CANCER and Role of The Excisision Repair Cross Complementation Group 1 (ERCC1) Protein Expression as A Predictive Factor of Platinum-Based Adjuvant Chemotherapy, RAMATHIBODI Experience

Piyawan Tienchaiananda, M.D., Touch Ativitavas, M.D., Mana Rochanawuth, M.D., Patcharee Karnsombut, M.D. ,Thitiya Sirisinha, M.D., Ekaphop Sirachainan, M.D., Ravat Panvichian, M.D. and Vorachai Ratanatharathorn, M.D.

September 9, 2016

Survival of Early Stage Breast Cancer: Rajavithi Hospital Experience

Ki Ruikchuchit, M.D., Sudsawat Laohavinij, Ph.D. M.D., and Jedzada Maneechavakajorn, M.D.

September 9, 2016

O-Methylguanine-DNA-Methyltransferase Expression in Thai Patients with Malignant Gliomas: Outcome and Response to treatment in Ramathibodi Hospital: a Retrospective Cohort Study

Wipawee Akwattanakul, M.D., Thitiya Sirisinha, M.D., Noppadol Larbcharoensub, M.D., Sasivimol Rattanasiri, M.D., Ekaphob Sirachainan, M.D., Ravat Panvichian, M.D., Touch Ativitavas, M.D., Vorachai Ratanatharathorn, M.D.

September 9, 2016

Randomized, double-blind, placebo-controlled trial of ondansetron plus dexamethasone with or without metoclopramide as antiemetic prophylaxis in patients receiving high dose cisplatin in medical practice

Kanakorn Runglodvatana, M.D., Akarin Nimmannit M.D., Apirom Laocharoenkeat, Charuwan Akewanlop,M.D., Vichien Srimuninnimit,M.D., Narong Keerativitayanan,M.D., Nopadol Soparattanapaisarn, M.D. and Suthinee Ithimakin, M.D.

September 9, 2016

Cost Analysis Between Tyrosine Kinase Inhibitor versus Docetaxel in Advanced Non-Small Cell Lung Cancer

Nuttapong Topibupong, M.D. and Virote Sriuranpong, M.D.